CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Plasmodium Immunotherapy for Advanced Ovarian Cancer | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 2 / Phase 3 | 2024-07-22 | NCT05924776 |